Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03412565 |
|---|---|
| Brief Title: | A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens |
| First Submitted : | January 22, 2018 |
| First Submitted that Met QC Criteria : | January 22, 2018 |
| First Posted : | January 26, 2018 |
| Results First Submitted : | December 16, 2021 |
| Results First Submitted that Met QC Criteria : | December 16, 2021 |
| Results First Posted : | January 12, 2022 |
| Certification/Extension First Submitted : | August 9, 2021 |
| Certification/Extension First Submitted that Met QC Criteria : | August 9, 2021 |
| Certification/Extension First Posted : | August 10, 2021 |
| Last Update Submitted that Met QC Criteria : | January 17, 2023 |
| Last Update Posted : | January 18, 2023 |